JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M609653200 on April 9, 2007

J. Biol. Chem., Vol. 282, Issue 26, 19190-19202, June 29, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/26/19190    most recent
M609653200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gong, X.-Q.
Right arrow Articles by Laird, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gong, X.-Q.
Right arrow Articles by Laird, D. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Differential Potency of Dominant Negative Connexin43 Mutants in Oculodentodigital Dysplasia*

Xiang-Qun Gong{ddagger}, Qing Shao§, Stéphanie Langlois§, Donglin Bai{ddagger}21, and Dale W. Laird{ddagger}§2

From the Departments of {ddagger}Physiology and Pharmacology and of §Anatomy and Cell Biology, University of Western Ontario, London, Ontario N6A 5C1, Canada

Oculodentodigital dysplasia (ODDD) is a congenital autosomal dominant disorder with phenotypic variability, which has been associated with mutations in the GJA1 gene encoding connexin43 (Cx43). Given that Cx43 mutants are thought to be equally co-expressed with wild-type Cx43 in ODDD patients, it is imperative to examine the consequence of these mutants in model systems that reflect this molar ratio. To that end, we used differential fluorescent protein tagging of mutant and wild-type Cx43 to quantitatively monitor the ratio of mutant/wild-type within the same putative gap junction plaques and co-immunoprecipitation to determine if the mutants interact with wild-type Cx43. Together the fluorescence-based assay was combined with patch clamp analysis to assess the dominant negative potency of Cx43 mutants. Our results revealed that the ODDD-linked Cx43 mutants, G21R and G138R, as well as amino terminus green fluorescent protein-tagged Cx43, were able to co-localize with wild-type Cx43 at the gap junction plaque-like structures and to co-immunoprecipitate with wild-type Cx43. All Cx43 mutants demonstrated dominant negative action on gap junctional conductance of wild-type Cx43 but not that of Cx32. More interestingly, these Cx43 mutants demonstrated different potencies in inhibiting the function of wild-type Cx43 with the G21R mutant being two times more potent than the G138R mutant. The potency difference in the dominant negative properties of ODDD-linked Cx43 mutants may have clinical implications for the various symptoms and disease severity observed in ODDD patients.


Received for publication, October 13, 2006 , and in revised form, April 3, 2007.

* This work was supported by the Canadian Institutes of Health Research (CIHR) and Canada Research Chair program (to D. B. and D. W. L.) and a CIHR Strategic Training Scholarship (to S. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

2 Both authors contributed equally to this work.

1 To whom correspondence should be addressed: Dept. of Physiology and Pharmacology, University of Western Ontario, London, Ontario N6A 5C1, Canada. Tel.: 519-850-2569; Fax: 519-850-2562; E-mail: donglin.bai{at}schulich.uwo.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. L. Manias, I. Plante, X.-Q. Gong, Q. Shao, J. Churko, D. Bai, and D. W. Laird
Fate of connexin43 in cardiac tissue harbouring a disease-linked connexin43 mutant
Cardiovasc Res, August 15, 2008; (2008) cvn203v2.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. W. Laird
Closing the Gap on Autosomal Dominant Connexin-26 and Connexin-43 Mutants Linked to Human Disease
J. Biol. Chem., February 8, 2008; 283(6): 2997 - 3001.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Langlois, A. C. Maher, J. L. Manias, Q. Shao, G. M. Kidder, and D. W. Laird
Connexin Levels Regulate Keratinocyte Differentiation in the Epidermis
J. Biol. Chem., October 12, 2007; 282(41): 30171 - 30180.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.